Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO).

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Evidence-based antiemetic guidelines offer predominantly consistent recommendations for chemotherapy-induced nausea and vomiting (CINV) prophylaxis. However, studies suggest that adherence to these recommendations is suboptimal. We explored inconsistencies between clinical practice and guideline-recommended treatment with a registry evaluating the effect of guideline-consistent CINV prophylaxis (GCCP) on patient outcomes.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Eur J Cancer

Title: European journal of cancer (Oxford, England : 1990)

Publisher: Elsevier BV

ISSN (Electronic): 1879-0852

ISSN (Print): 0959-8049

Publication date (Electronic): May 2022

Volume: 166

Affiliations

[1 ] Oncology Department, Genolier Cancer Center, Clinique de Genolier, Genolier, Switzerland. Electronic address: maapro@genolier.net.

[2 ] Oncomed, Timisoara, Romania.

[3 ] Complex Oncology Center, Stara Zagora, Stara Zagora, Bulgaria.

[4 ] Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.

[5 ] Emergency County Hospital, Alba Iulia, Romania.

[6 ] Department of Medical Oncology, Clinical Hospital for Nephrology "Carol Davila" Bucharest, Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

[7 ] Department of Medical Oncology, Clinical Hospital for Nephrology "Carol Davila" Bucharest, Bucharest, Romania.

[8 ] Radiotherapy Department, Genetic Outpatient Clinic, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland.

[9 ] Medical Department, Angelini Pharma, Česká republika s.r.o., Brno, Czech Republic.

[10 ] Clinical Oncology Department, National Cancer Institute, Bratislava, Slovak Republic.

[11 ] Grigore T. Popa University of Medicine and Pharmacy, Regional Oncology Institute, Iasi, Romania.

[12 ] Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.

[13 ] Lung Cancer and Chest Tumors Department, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland.

[14 ] Department of Oncology, 2(nd) Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.

[15 ] Department of Oncology, East Slovakian Institute of Oncology, Košice, Slovak Republic.

[16 ] Chemotherapy Day Ward, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland.

[17 ] Division of Oncology, Department of Internal Medicine I and Gaston H. Glock - Research Center, Medical University of Vienna, Vienna, Austria.

[18 ] Department of Oncology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

[19 ] University Hospital Martin, Martin, Slovak Republic.

[20 ] Department Medical Oncology, Medical University - Sofia, Affiliation - Vratsa, Comprehensive Cancer Center - Vratsa, Vratsa, Bulgaria.

[21 ] Szpital Świętej Rodziny, Oddział Onkologiczny, Warsaw, Poland.

Article

Publisher Item ID: S0959-8049(22)00061-2

DOI: 10.1016/j.ejca.2022.01.028

PubMed ID: 35290913

SO-VID: 6aac336c-2b5f-4dc8-9e40-0928d11fae61

History

Keywords: Guidelines,Antiemetic,CINV,Compliance,Vomiting,Nausea

Data availability:

Keywords: Guidelines, Antiemetic, CINV, Compliance, Vomiting, Nausea

Comments

Comment on this article

scite_

Cited by 2

See all cited by